HK1047227A1 - Formulations for parenteral use of estramustine phosphate with improved pharma-cological properties - Google Patents

Formulations for parenteral use of estramustine phosphate with improved pharma-cological properties

Info

Publication number
HK1047227A1
HK1047227A1 HK02108529.1A HK02108529A HK1047227A1 HK 1047227 A1 HK1047227 A1 HK 1047227A1 HK 02108529 A HK02108529 A HK 02108529A HK 1047227 A1 HK1047227 A1 HK 1047227A1
Authority
HK
Hong Kong
Prior art keywords
formulations
parenteral use
estramustine phosphate
cological properties
pharma
Prior art date
Application number
HK02108529.1A
Other languages
Chinese (zh)
Inventor
L‧穆蓋蒂
P‧哥倫布
A‧馬爾蒂尼
G‧布茲
Original Assignee
法瑪西雅意大利公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 法瑪西雅意大利公司 filed Critical 法瑪西雅意大利公司
Publication of HK1047227A1 publication Critical patent/HK1047227A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02108529.1A 1999-09-16 2002-11-26 Formulations for parenteral use of estramustine phosphate with improved pharma-cological properties HK1047227A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921954.5A GB9921954D0 (en) 1999-09-16 1999-09-16 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
PCT/EP2000/007679 WO2001019338A1 (en) 1999-09-16 2000-08-03 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties

Publications (1)

Publication Number Publication Date
HK1047227A1 true HK1047227A1 (en) 2003-02-14

Family

ID=10861066

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108529.1A HK1047227A1 (en) 1999-09-16 2002-11-26 Formulations for parenteral use of estramustine phosphate with improved pharma-cological properties

Country Status (20)

Country Link
EP (1) EP1212040A1 (en)
JP (1) JP2003509355A (en)
KR (1) KR20020059405A (en)
CN (1) CN1177583C (en)
AU (1) AU777763B2 (en)
BR (1) BR0014063A (en)
CA (1) CA2385063A1 (en)
CZ (1) CZ2002943A3 (en)
EA (1) EA005308B1 (en)
GB (1) GB9921954D0 (en)
HK (1) HK1047227A1 (en)
HU (1) HUP0202621A2 (en)
IL (1) IL148409A0 (en)
MX (1) MXPA02002859A (en)
NO (1) NO20021306L (en)
NZ (1) NZ517631A (en)
PL (1) PL353954A1 (en)
SK (1) SK3452002A3 (en)
WO (1) WO2001019338A1 (en)
ZA (1) ZA200201743B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658913B2 (en) 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
US9215679B2 (en) 2010-09-21 2015-12-15 Telefonaktiebolaget L M Ericsson (Publ) Air-interface timing synchronization sharing
WO2019094819A2 (en) * 2017-11-09 2019-05-16 Abon Pharmaceuticals, Llc Intravenous delivery systems for chemotherapy drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59108800A (en) * 1982-12-13 1984-06-23 Japan Atom Energy Res Inst Fine particle having guided missile action and slow-releasing function of carcinostatic agent
KR0166088B1 (en) * 1990-01-23 1999-01-15 . Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
GB9419153D0 (en) * 1994-09-22 1994-11-09 Erba Carlo Spa Estramustine formulations with improved pharmaceutical properties
US20020039594A1 (en) * 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same

Also Published As

Publication number Publication date
CN1374858A (en) 2002-10-16
NZ517631A (en) 2004-01-30
GB9921954D0 (en) 1999-11-17
NO20021306L (en) 2002-04-24
KR20020059405A (en) 2002-07-12
WO2001019338A1 (en) 2001-03-22
ZA200201743B (en) 2003-05-28
AU6836300A (en) 2001-04-17
BR0014063A (en) 2004-06-29
CA2385063A1 (en) 2001-03-22
IL148409A0 (en) 2002-09-12
EA200200369A1 (en) 2002-08-29
NO20021306D0 (en) 2002-03-15
CZ2002943A3 (en) 2002-08-14
JP2003509355A (en) 2003-03-11
EA005308B1 (en) 2004-12-30
EP1212040A1 (en) 2002-06-12
PL353954A1 (en) 2003-12-15
AU777763B2 (en) 2004-10-28
MXPA02002859A (en) 2003-07-21
SK3452002A3 (en) 2002-08-06
CN1177583C (en) 2004-12-01
HUP0202621A2 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
EP1117159A3 (en) Connector
GB0012247D0 (en) Connector
GB2347797B (en) Coaxial connector
AU1893901A (en) Connector
PL342733A1 (en) Biocement of improved properties
AU4604500A (en) Swivel connector
HK1047227A1 (en) Formulations for parenteral use of estramustine phosphate with improved pharma-cological properties
GB0008127D0 (en) Connector
GB9921958D0 (en) Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
HUP0203384A3 (en) Process for the preparation of ketimines
HUP0202645A3 (en) Fornulations for parenteral use of estramustine phosphate and albumin
AU138912S (en) Connector
TW435837U (en) Structure improvement of connector
HUP0203382A3 (en) Process for the preparation of ketimines
GB9903574D0 (en) Connector
AU142885S (en) Connector
TW443639U (en) Improved structure of coaxial connector
TW421348U (en) Improved structure of coaxial connector
TW411988U (en) Pipe connector improvement of the union
TW424959U (en) Structure improvement of SMA connector
TW411045U (en) Improvement for case structure of circular connector
TW452268U (en) Improved structure of coaxial pipeline connector
IL132855A0 (en) Disengagement of coupled connectors
TW414404U (en) Structure improvement of connector
TW422462U (en) Card-inserting structure of connector